Monashee Investment Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Monashee Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$65.78 - $105.02 $6.58 Million - $10.5 Million	-100,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $6.41 Million - $9.18 Million	100,000 New	100,000 $6.84 Million
Q3 2019 Nov 12, 2019	SELL	$37.38 - $49.47 $3.74 Million - $4.95 Million	-100,000 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$39.79 - $67.01 $3.98 Million - $6.7 Million	100,000 New	100,000 $4.38 Million
Q4 2017 Feb 09, 2018	SELL	$20.44 - $35.56 $408,800 - $711,200	-20,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$23.54 - $38.21 $470,800 - $764,200	20,000	20,000 $748,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.